Galieve Dual Peppermint: Uses, Dosage & Side Effects

An alginate-antacid combination oral suspension for the relief of heartburn, acid reflux, and indigestion associated with gastroesophageal reflux

Rx ATC: A02BX13 Alginate-Antacid
Active Ingredients
Sodium alginate, Sodium bicarbonate, Calcium carbonate
Available Forms
Oral suspension
Strength
500 mg / 213 mg / 325 mg per 10 mL
Brand Names
Galieve Dual Peppermint

Galieve Dual Peppermint is an oral suspension containing three active ingredients — sodium alginate (500 mg), sodium bicarbonate (213 mg), and calcium carbonate (325 mg) per 10 mL dose — used for the symptomatic relief of heartburn, acid reflux (gastroesophageal reflux), and indigestion. It works through a unique dual mechanism: the sodium alginate reacts with stomach acid to form a protective gel raft that floats on top of the stomach contents, physically preventing acid from refluxing into the esophagus, while the antacid components rapidly neutralize excess gastric acid for immediate symptom relief. This combination provides both fast-acting relief, typically within 3–5 minutes, and sustained protection lasting up to 4 hours. Galieve Dual Peppermint is a peppermint-flavored suspension that is taken orally after meals and at bedtime.

Quick Facts: Galieve Dual Peppermint

Active Ingredients
Alginate + Antacids
Drug Class
Reflux Suppressant
ATC Code
A02BX13
Common Uses
Heartburn & Reflux
Available Forms
Oral Suspension
Prescription Status
Rx

Key Takeaways

  • Galieve Dual Peppermint combines sodium alginate with antacids (sodium bicarbonate and calcium carbonate) to provide both a physical barrier against acid reflux and rapid acid neutralization for immediate heartburn relief.
  • The alginate raft mechanism is unique: it forms a viscous gel that floats on stomach contents, physically preventing gastric acid from reaching the esophagus, with protection lasting up to 4 hours after each dose.
  • Onset of action is rapid, typically within 3–5 minutes, making it effective for on-demand symptomatic relief of heartburn, acid regurgitation, and indigestion after meals.
  • Alginate-antacid products are generally considered safe during pregnancy and are recommended as first-line treatment for pregnancy-related heartburn by multiple clinical guidelines including NICE.
  • Take other medications at least 2 hours before or after Galieve Dual Peppermint to avoid potential interactions with drug absorption, particularly with antibiotics, iron supplements, and thyroid medications.

What Is Galieve Dual Peppermint and What Is It Used For?

Quick Answer: Galieve Dual Peppermint is an oral suspension containing sodium alginate, sodium bicarbonate, and calcium carbonate. It is used for the symptomatic treatment of gastroesophageal reflux conditions such as heartburn, acid regurgitation, and indigestion. It works by forming a protective raft on stomach contents while simultaneously neutralizing excess stomach acid.

Galieve Dual Peppermint belongs to the pharmacological class of alginate-antacid combination products, also known as reflux suppressants. This class of medications is specifically designed to address the symptoms of gastroesophageal reflux disease (GERD) and related conditions through a unique dual mechanism of action that differentiates them from simple antacids or acid-suppressing drugs such as proton pump inhibitors (PPIs) and histamine-2 receptor antagonists (H2RAs).

The product contains three active ingredients that work synergistically. Sodium alginate (500 mg per 10 mL dose) is a naturally derived polysaccharide extracted from brown seaweed (Phaeophyceae). When sodium alginate comes into contact with gastric acid, it undergoes a chemical reaction to form alginic acid, which precipitates as a viscous, gel-like structure. In the presence of sodium bicarbonate, carbon dioxide is generated, which becomes trapped within the alginate gel matrix, causing it to float on top of the stomach contents. This floating gel structure is commonly referred to as an "alginate raft." The raft acts as a physical barrier, sitting on top of the gastric pool and preventing the reflux of acidic stomach contents into the esophagus. Studies using gamma scintigraphy and magnetic resonance imaging (MRI) have confirmed that the alginate raft forms within minutes of ingestion and can persist in the stomach for up to 4 hours, providing sustained mechanical protection against reflux episodes.

Sodium bicarbonate (213 mg per 10 mL dose) serves a dual purpose in the formulation. First, it acts as an antacid, rapidly neutralizing hydrochloric acid in the stomach to raise intragastric pH and provide immediate relief from the burning sensation of heartburn. Second, the carbon dioxide produced by the reaction between sodium bicarbonate and gastric acid is essential for the buoyancy of the alginate raft, ensuring that the raft floats effectively on top of the stomach contents rather than sinking or mixing into the gastric pool. This buoyancy mechanism is critical to the product's reflux-suppressing action.

Calcium carbonate (325 mg per 10 mL dose) provides additional antacid capacity and also contributes to the structural integrity of the alginate raft through calcium-mediated cross-linking of alginate polymer chains. Calcium ions interact with the alginate gel to form a stronger, more cohesive raft structure. The calcium carbonate also buffers gastric acid independently of the sodium bicarbonate, extending the duration of acid neutralization. This combination of structural reinforcement and acid neutralization makes calcium carbonate an essential component of the formulation's overall efficacy.

Galieve Dual Peppermint is indicated for the symptomatic treatment of the following conditions:

  • Heartburn (pyrosis): The burning sensation in the chest or throat caused by acid reflux, typically occurring after meals, when bending over, or when lying down. Heartburn is the most common symptom of GERD and affects approximately 10–20% of the adult population in Western countries on a weekly basis.
  • Acid regurgitation: The sensation of acidic or bitter-tasting fluid rising from the stomach into the throat or mouth. This symptom is often worse after large meals, when lying flat, or during physical activities that increase intra-abdominal pressure.
  • Indigestion (dyspepsia): A group of symptoms including upper abdominal discomfort, bloating, fullness, and nausea that may accompany gastroesophageal reflux. Functional dyspepsia affects up to 20% of the general population globally.

The unique raft-forming mechanism of alginate-antacid products has been validated in numerous clinical studies and systematic reviews. A landmark randomized controlled trial published in Alimentary Pharmacology & Therapeutics demonstrated that alginate-antacid combinations were significantly more effective than antacids alone in reducing reflux episodes and heartburn severity. A Cochrane-style systematic review of alginate-based therapies confirmed their efficacy for the management of GERD symptoms, with the alginate raft providing superior reflux suppression compared to conventional antacids. The British National Formulary (BNF) and the National Institute for Health and Care Excellence (NICE) recommend alginate-antacid combinations as first-line therapy for mild to moderate GERD symptoms, particularly in cases where lifestyle modifications alone are insufficient.

How the Alginate Raft Works

When you take Galieve Dual Peppermint, the sodium alginate reacts with stomach acid to form a gel. The sodium bicarbonate produces carbon dioxide bubbles that get trapped in this gel, making it float like a raft on top of your stomach contents. This floating raft acts as a physical lid, preventing acid from splashing up into your esophagus. Meanwhile, the calcium carbonate and sodium bicarbonate neutralize excess acid in your stomach for immediate relief. This dual action — physical barrier plus acid neutralization — is what makes alginate-antacid products unique among reflux treatments.

What Should You Know Before Taking Galieve Dual Peppermint?

Quick Answer: Before taking Galieve Dual Peppermint, inform your doctor if you have kidney disease, heart failure, or are on a sodium-restricted diet. The product contains sodium, which may be relevant for patients managing cardiovascular or renal conditions. Do not use if you are allergic to any of the ingredients.

Contraindications

Galieve Dual Peppermint should not be used by individuals who have a known hypersensitivity (allergy) to sodium alginate, sodium bicarbonate, calcium carbonate, or any of the excipients contained in the formulation. Allergic reactions to alginate-based products are extremely rare, but as with any medication, patients with a history of allergic reactions to any component should avoid use. Symptoms of a rare allergic reaction may include skin rash, itching, swelling of the face, lips, tongue, or throat, difficulty breathing, or dizziness.

The product contains sodium, which may be a concern for patients on sodium-restricted diets. Each 10 mL dose of Galieve Dual Peppermint contains a clinically relevant amount of sodium. Patients with conditions requiring strict sodium restriction, such as congestive heart failure, severe hypertension, or certain kidney diseases, should consult their healthcare provider before use. In these patients, the cumulative sodium intake from multiple daily doses may be clinically significant and could contribute to fluid retention, edema, or worsening of blood pressure control.

Patients with severe renal impairment should use Galieve Dual Peppermint with caution, as impaired kidney function may reduce the ability to excrete the additional calcium and sodium absorbed from the product. Prolonged use of calcium-containing antacids in patients with renal impairment can lead to hypercalcemia (elevated blood calcium levels), which may cause symptoms such as nausea, vomiting, confusion, and in severe cases, cardiac arrhythmias.

Warnings and Precautions

If symptoms of heartburn or acid reflux persist for more than 7 days despite regular use of Galieve Dual Peppermint, or if symptoms worsen, patients should consult a healthcare professional. Persistent or worsening reflux symptoms may indicate a more serious underlying condition that requires further investigation, such as erosive esophagitis, Barrett's esophagus, or, in rare cases, gastric or esophageal malignancy. Alarm symptoms that warrant immediate medical evaluation include unintentional weight loss, difficulty swallowing (dysphagia), persistent vomiting, vomiting blood (hematemesis), or black tarry stools (melena).

Patients with phenylketonuria (PKU) should check whether the specific formulation contains aspartame, as some oral suspension formulations may use artificial sweeteners. The peppermint flavoring is generally well tolerated, but patients with known sensitivity to peppermint oil should be aware of its presence in the formulation.

The calcium carbonate component may cause alkalosis (an excessively alkaline state of the blood) if the product is used in very high doses or for prolonged periods, particularly in patients with renal impairment. This condition, historically known as milk-alkali syndrome, can lead to hypercalcemia, metabolic alkalosis, and renal impairment. Patients should not exceed the recommended daily dose and should not use the product continuously for extended periods without medical supervision.

Important Warning

Do not exceed the maximum recommended daily dose. If symptoms persist for more than 7 days, or if you experience difficulty swallowing, persistent vomiting, unintentional weight loss, or vomiting blood, seek medical attention promptly as these may indicate a more serious condition requiring investigation.

Pregnancy and Breastfeeding

Heartburn and acid reflux are extremely common during pregnancy, affecting an estimated 40–80% of pregnant women, particularly during the second and third trimesters. The increased prevalence is primarily due to hormonal changes (elevated progesterone levels cause relaxation of the lower esophageal sphincter) and mechanical factors (the enlarging uterus increases intra-abdominal pressure, promoting reflux of gastric contents).

Alginate-antacid combination products such as Galieve Dual Peppermint are generally considered safe to use during pregnancy when used as directed. In fact, they are among the first-line pharmacological treatments recommended for pregnancy-related heartburn by several clinical guidelines, including those from the National Institute for Health and Care Excellence (NICE) and the British National Formulary (BNF). A large observational study published in the British Journal of Clinical Pharmacology found no increased risk of congenital malformations, preterm birth, or low birth weight associated with alginate-antacid use during pregnancy.

However, as with all medications during pregnancy, patients should consult their healthcare provider before starting treatment. Pregnant women with pre-eclampsia or pregnancy-induced hypertension should be cautious about the sodium content of the product. Calcium supplementation from the calcium carbonate component is generally considered beneficial during pregnancy, as many pregnant women require additional calcium intake.

There is limited specific data on the excretion of alginates into breast milk. However, sodium alginate is not systemically absorbed to a significant degree, as it acts locally in the stomach. The small amounts of calcium and sodium absorbed from the product are unlikely to affect the breastfed infant. Alginate-antacid products are generally considered compatible with breastfeeding, although patients should consult a healthcare professional if they have concerns.

How Does Galieve Dual Peppermint Interact with Other Drugs?

Quick Answer: Galieve Dual Peppermint can reduce the absorption of certain medications by altering gastric pH or through physical binding of drugs to the alginate gel. As a general rule, take other oral medications at least 2 hours before or after taking Galieve Dual Peppermint. Key interactions include tetracycline antibiotics, fluoroquinolones, iron supplements, levothyroxine, and bisphosphonates.

As with all antacid-containing products, Galieve Dual Peppermint has the potential to interact with other orally administered medications through two primary mechanisms. First, the antacid components (sodium bicarbonate and calcium carbonate) raise the intragastric pH, which can alter the dissolution, absorption, and bioavailability of medications whose absorption is pH-dependent. Second, the alginate gel and calcium ions can physically bind to certain drugs, reducing their absorption from the gastrointestinal tract. For these reasons, a general recommendation applies: take other oral medications at least 2 hours before or after Galieve Dual Peppermint to minimize the potential for interactions.

Major Interactions

Certain medications require strict separation from alginate-antacid products due to clinically significant reductions in absorption:

Major Drug Interactions
Medication Interaction Recommendation
Tetracycline antibiotics (e.g., doxycycline, tetracycline) Calcium and altered pH significantly reduce tetracycline absorption by 50–90% Take antibiotics at least 2–3 hours before or after
Fluoroquinolone antibiotics (e.g., ciprofloxacin, levofloxacin) Calcium chelation reduces fluoroquinolone bioavailability by up to 90% Take antibiotics at least 2 hours before or 6 hours after
Levothyroxine (thyroid hormones) Calcium and alginate bind to levothyroxine, reducing absorption Take levothyroxine at least 4 hours before antacid
Iron supplements (ferrous sulfate, ferrous fumarate) Calcium competes for absorption; raised pH reduces iron solubility Separate administration by at least 2–3 hours
Bisphosphonates (e.g., alendronate, risedronate) Calcium and antacids severely reduce bisphosphonate absorption Take bisphosphonate at least 30 minutes before any food or antacid

Minor Interactions

Several other medications may have their absorption modestly affected by concurrent administration with Galieve Dual Peppermint. While these interactions are generally less clinically significant, separation of doses is still recommended as a precaution:

  • Proton pump inhibitors (PPIs): Although PPIs and alginate-antacids are sometimes used together for GERD, co-administration at the same time may reduce PPI absorption. Take PPIs 30 minutes before meals and separate from antacid use.
  • H2 receptor antagonists (e.g., ranitidine, famotidine): Simultaneous administration may slightly reduce H2RA absorption, though this interaction is rarely clinically significant.
  • Digoxin: Antacids may slightly reduce digoxin absorption. Patients on digoxin should maintain consistent timing between doses.
  • Ketoconazole and itraconazole: These antifungal agents require an acidic environment for optimal absorption. Concurrent antacid use may reduce their bioavailability. Take antifungals at least 2 hours before antacids.
  • Mycophenolate mofetil: Antacids containing calcium or magnesium can reduce the absorption of mycophenolate. Separate doses by at least 2 hours.
General Guidance on Drug Interactions

The simplest way to avoid interactions with Galieve Dual Peppermint is to take other medications at least 2 hours before or after your dose. If you take multiple medications, ask your pharmacist to help you create a dosing schedule that minimizes interaction risks. Always inform your doctor and pharmacist about all medications, supplements, and herbal products you are taking.

What Is the Correct Dosage of Galieve Dual Peppermint?

Quick Answer: The standard adult dose of Galieve Dual Peppermint is 10–20 mL (one to two 5 mL spoonfuls or the measuring cup provided), taken after meals and at bedtime, up to 4 times daily. Shake the bottle well before each use. Do not exceed 80 mL in 24 hours.

Galieve Dual Peppermint is an oral suspension that should be shaken well before each use to ensure uniform distribution of the active ingredients. The suspension should be taken by mouth, ideally after meals and at bedtime, as these are the times when gastroesophageal reflux is most likely to occur. Food distends the stomach and relaxes the lower esophageal sphincter, increasing the likelihood of reflux, while lying down at night removes the protective effect of gravity, allowing stomach contents to reflux more easily into the esophagus.

Adults

Standard Adult Dose (18 years and over)

Dose: 10–20 mL per administration

Frequency: After meals and at bedtime (up to 4 times daily)

Maximum daily dose: 80 mL in 24 hours

Administration: Shake well before use. Take by mouth. Use the measuring cup or spoon provided.

The timing of administration is important for optimal efficacy. Taking the suspension after meals allows the alginate to form a raft on top of the food-acid mixture in the stomach, providing maximum protection against postprandial reflux. The bedtime dose is particularly important for patients who experience nocturnal reflux or morning heartburn, as it provides a protective barrier during the overnight period when supine positioning increases reflux risk. Clinical studies have demonstrated that the alginate raft can persist in the stomach for up to 4 hours after ingestion, which correlates well with the recommended dosing interval.

Children

Children (12 years and over)

Dose: 10–20 mL per administration (same as adult dose)

Frequency: After meals and at bedtime (up to 4 times daily)

Maximum daily dose: 80 mL in 24 hours

Children (under 12 years)

Dose: Not recommended unless directed by a physician

The safety and efficacy of Galieve Dual Peppermint in children under 12 years have not been established. Pediatric GERD should be managed under the guidance of a pediatrician, and other age-appropriate formulations or treatments may be available.

Elderly

Elderly Patients (65 years and over)

Dose: 10–20 mL per administration (same as adult dose)

No dose adjustment is generally required for elderly patients. However, elderly individuals may be more susceptible to electrolyte disturbances from antacid use and should be monitored if using the product regularly. Elderly patients with renal impairment should use the product with caution due to reduced capacity to excrete excess calcium and sodium. Additionally, elderly patients often take multiple medications, so particular attention should be paid to potential drug interactions.

Missed Dose

Galieve Dual Peppermint is taken on an as-needed basis for symptomatic relief rather than on a fixed dosing schedule. Therefore, there is no concern about missed doses in the traditional sense. If you forget to take a dose after a meal and subsequently experience heartburn or reflux symptoms, you may take the suspension at that time. Do not take a double dose to compensate for a missed one. Simply resume your regular dosing pattern with the next meal or at bedtime.

Overdose

Accidental overdose with Galieve Dual Peppermint is unlikely to cause serious harm in most individuals, as the active ingredients have a wide margin of safety. However, ingestion of very large amounts may lead to gastrointestinal symptoms such as bloating, flatulence, or abdominal discomfort due to excess gas production from the reaction between sodium bicarbonate and gastric acid. In extreme cases, excessive intake of calcium carbonate can lead to hypercalcemia, metabolic alkalosis, or, with prolonged massive overuse, the development of milk-alkali syndrome characterized by hypercalcemia, renal insufficiency, and metabolic alkalosis.

The high sodium content of large doses could also be problematic for patients with heart failure, hypertension, or renal disease. In the event of significant overdose, symptomatic treatment should be provided. If you suspect an overdose, contact your local poison control center or seek medical attention.

Overdose Warning

Do not exceed 80 mL in 24 hours. In case of accidental overdose, contact your local poison control center or seek emergency medical attention, especially if symptoms such as nausea, vomiting, confusion, or irregular heartbeat develop.

What Are the Side Effects of Galieve Dual Peppermint?

Quick Answer: Galieve Dual Peppermint is generally very well tolerated, with side effects being uncommon. The most commonly reported effects include mild gastrointestinal symptoms such as bloating or flatulence. Very rare allergic reactions have been reported. The product has an established safety profile with decades of clinical use.

Alginate-antacid combination products have been available for clinical use for over four decades and have accumulated an extensive safety record across millions of patients worldwide. Galieve Dual Peppermint is generally considered to be very well tolerated, with a low incidence of adverse effects. The active ingredients act primarily locally in the stomach, with minimal systemic absorption of the alginate component. The antacid components (sodium bicarbonate and calcium carbonate) are partially absorbed, but at the recommended doses, systemic effects are unlikely in patients with normal renal function.

The following side effects have been reported with alginate-antacid products. They are organized by frequency according to the Council for International Organizations of Medical Sciences (CIOMS) classification:

Uncommon

May affect up to 1 in 100 people

  • Bloating or abdominal distension (due to carbon dioxide gas production)
  • Flatulence (excess gas)
  • Nausea
  • Constipation (primarily related to calcium carbonate)

Rare

May affect up to 1 in 1,000 people

  • Diarrhea
  • Abdominal pain or discomfort
  • Eructation (belching)

Very Rare / Not Known

Frequency cannot be estimated from available data

  • Allergic reactions (hypersensitivity), including urticaria (hives)
  • Angioedema (swelling of face, lips, tongue, or throat)
  • Anaphylactic/anaphylactoid reactions (extremely rare)
  • Bronchospasm (breathing difficulties) in hypersensitive individuals
  • Hypercalcemia (elevated blood calcium) with prolonged high-dose use
  • Metabolic alkalosis with prolonged high-dose use, particularly in renal impairment

It is important to note that many of the gastrointestinal side effects listed above (bloating, flatulence) are mild and self-limiting, often resolving with continued use or dose adjustment. The carbon dioxide gas produced by the reaction between sodium bicarbonate and gastric acid is the primary cause of bloating and flatulence symptoms. This is a natural consequence of the product's mechanism of action and is generally not considered harmful.

Prolonged use of calcium-containing antacids at high doses can theoretically lead to hypercalcemia and milk-alkali syndrome, but this is extremely unlikely at the recommended doses of Galieve Dual Peppermint. Patients with normal renal function are able to efficiently regulate calcium homeostasis and excrete excess calcium through the kidneys. However, patients with chronic kidney disease (CKD) stages 3–5 should be monitored for electrolyte abnormalities if using the product regularly.

The sodium content of the product should be considered for patients on sodium-restricted diets or those with conditions sensitive to sodium load, such as heart failure, cirrhosis with ascites, or nephrotic syndrome. Healthcare providers should weigh the benefits of symptom relief against the sodium load when recommending the product to these patient populations.

When to Seek Medical Attention

Stop taking Galieve Dual Peppermint and seek immediate medical attention if you experience signs of a severe allergic reaction: sudden onset of swelling of the face, lips, tongue, or throat; difficulty breathing or swallowing; severe skin rash or hives; dizziness or feeling faint. These reactions are extremely rare but require emergency medical care.

How Should You Store Galieve Dual Peppermint?

Quick Answer: Store Galieve Dual Peppermint at room temperature below 25°C (77°F). Do not freeze. Keep the bottle tightly closed. Use within the specified period after first opening (check product label). Keep out of reach and sight of children.

Proper storage of Galieve Dual Peppermint is essential to maintain the product's efficacy, stability, and safety throughout its shelf life. The oral suspension is a complex pharmaceutical formulation that requires appropriate storage conditions to preserve the integrity of its active ingredients and ensure consistent quality from the first dose to the last.

The product should be stored at room temperature, typically defined as below 25°C (77°F), in a location that is not exposed to direct sunlight, heat sources, or excessive humidity. Do not refrigerate or freeze the suspension, as extreme cold temperatures can alter the viscosity and suspension properties of the formulation, potentially affecting the uniformity of the active ingredients and the product's ability to form an effective alginate raft. Freezing may cause irreversible changes to the formulation's physical characteristics.

After first opening the bottle, the oral suspension should be used within the period specified on the product label (typically 6 months, but refer to the specific product packaging for the exact duration). After this period, the product should be discarded, even if the contents appear unchanged, as microbiological contamination or chemical degradation may have occurred. Always check the expiration date on the packaging before use, and do not use the product after the expiration date has passed.

Keep the bottle tightly closed when not in use to prevent contamination, evaporation, and deterioration of the suspension. Shake the bottle thoroughly before each use to ensure that the active ingredients are evenly distributed throughout the suspension. If the suspension appears unusual in color, consistency, or odor, or if visible particles are present, do not use the product and consult your pharmacist.

As with all medications, keep Galieve Dual Peppermint out of the reach and sight of children. Do not dispose of the product via household waste or wastewater; instead, ask your pharmacist about local medication disposal programs to ensure environmentally responsible disposal.

What Does Galieve Dual Peppermint Contain?

Quick Answer: Each 10 mL dose of Galieve Dual Peppermint contains sodium alginate 500 mg, sodium bicarbonate 213 mg, and calcium carbonate 325 mg as active ingredients. The suspension also contains excipients including peppermint flavoring, preservatives, and sweeteners. The product is a white to off-white viscous suspension with a characteristic peppermint taste.

Galieve Dual Peppermint is a pharmaceutical oral suspension containing both active ingredients and inactive ingredients (excipients) that together form a stable, palatable, and effective medication. Understanding the composition is important for patients with allergies, dietary restrictions, or specific medical conditions.

Active Ingredients (per 10 mL dose)

Active Ingredients per 10 mL Dose
Ingredient Amount Function
Sodium alginate 500 mg Forms a protective raft on stomach contents to prevent reflux
Sodium bicarbonate 213 mg Neutralizes stomach acid; generates CO₂ for raft buoyancy
Calcium carbonate 325 mg Neutralizes stomach acid; strengthens alginate raft structure

Excipients (Inactive Ingredients)

The excipients in Galieve Dual Peppermint serve various pharmaceutical purposes including suspension stabilization, flavor enhancement, preservation, and palatability. Common excipients found in this type of formulation may include:

  • Carbomer: A polymer used as a suspending agent to maintain uniform distribution of active ingredients throughout the suspension.
  • Peppermint flavoring: Provides the characteristic peppermint taste that improves palatability and patient acceptance.
  • Methyl parahydroxybenzoate (E218) and propyl parahydroxybenzoate (E216): Preservatives used to prevent microbial growth in the aqueous suspension. Patients with known hypersensitivity to parabens should be aware of their presence.
  • Sodium saccharin: An artificial sweetener used to improve the taste of the suspension without adding sugar.
  • Sodium hydroxide: Used for pH adjustment during manufacturing to optimize the stability of the formulation.
  • Purified water: The vehicle (solvent) for the oral suspension.

Patients with specific allergies or intolerances should carefully review the full list of ingredients on the product packaging or patient information leaflet before use. If you have any questions about the ingredients, consult your pharmacist or healthcare provider. Note that the exact excipient composition may vary slightly between different manufacturers and formulations, so always refer to the specific product packaging.

Sodium Content Information

Galieve Dual Peppermint contains sodium from both the sodium alginate and sodium bicarbonate components. Each 10 mL dose contains a significant amount of sodium. This information is important for patients on sodium-restricted diets (e.g., those with heart failure, severe hypertension, or kidney disease). If you are on a medically prescribed low-sodium diet, discuss the sodium content with your healthcare provider before use.

Frequently Asked Questions About Galieve Dual Peppermint

Regular antacids (such as calcium carbonate tablets or aluminum hydroxide) work solely by chemically neutralizing stomach acid. While effective for short-term relief, they do not address the physical mechanism of reflux. Galieve Dual Peppermint combines antacid action with a unique alginate raft-forming mechanism. The sodium alginate forms a physical gel barrier that floats on stomach contents, actively preventing acid from refluxing into the esophagus. This dual approach provides both immediate acid neutralization (within 3–5 minutes) and sustained physical protection against reflux for up to 4 hours — making it more effective than antacids alone for managing reflux symptoms.

Yes, Galieve Dual Peppermint can generally be used alongside proton pump inhibitors (PPIs) such as omeprazole, esomeprazole, or lansoprazole. In fact, some patients with moderate to severe GERD may benefit from combining a PPI (for sustained acid suppression) with an alginate-antacid product (for on-demand relief of breakthrough symptoms). However, to avoid any potential interference with PPI absorption, take your PPI 30 minutes before a meal and take Galieve Dual Peppermint after the meal. Always consult your doctor before combining medications.

Alginate-antacid products are generally considered safe during pregnancy and are recommended as first-line pharmacological treatment for pregnancy-related heartburn by clinical guidelines including NICE and BNF. The sodium alginate works locally in the stomach with minimal systemic absorption. However, pregnant women should not exceed the recommended dose and should be aware of the sodium content, particularly those with pregnancy-induced hypertension or pre-eclampsia. Always consult your healthcare provider before starting any medication during pregnancy.

Galieve Dual Peppermint begins to work within 3 to 5 minutes of ingestion. The antacid components (sodium bicarbonate and calcium carbonate) immediately start neutralizing excess stomach acid, providing rapid relief from the burning sensation of heartburn. Simultaneously, the alginate raft forms within minutes and floats on top of the stomach contents, creating a physical barrier that prevents acid from refluxing into the esophagus. This protective barrier can last for up to 4 hours, providing sustained relief from reflux symptoms.

Galieve Dual Peppermint is primarily intended for short-term, on-demand relief of reflux symptoms. While alginate-antacid products have a well-established safety profile, regular use for more than 7 days without medical advice is not recommended, as persistent symptoms may indicate a more serious underlying condition requiring investigation. If you find yourself needing the product regularly, consult your doctor for a thorough evaluation. Long-term regular use at high doses may lead to electrolyte imbalances, particularly in patients with renal impairment, and can also mask symptoms of conditions that require specific treatment.

Galieve Dual Peppermint should be taken after meals and at bedtime for optimal effectiveness. Taking it after meals allows the alginate raft to form on top of the food and acid mixture in the stomach, providing maximum protection against postprandial (after-meal) reflux. The bedtime dose is important for preventing nocturnal reflux, which can be particularly troublesome when lying down removes the protective effect of gravity. Avoid taking the suspension on an empty stomach, as there needs to be gastric acid present for the alginate raft to form properly.

References & Medical Sources

  1. National Institute for Health and Care Excellence (NICE). Clinical Knowledge Summaries: Dyspepsia – unvestigated dyspepsia. Last revised 2024. Available at: cks.nice.org.uk
  2. British National Formulary (BNF). Sodium alginate with calcium carbonate and sodium bicarbonate. 2025 Edition. London: BMJ Group and Pharmaceutical Press.
  3. Leiman DA, Riff BP, Morgan S, et al. Alginate therapy is effective treatment for GERD symptoms: a systematic review and meta-analysis. Diseases of the Esophagus. 2017;30(5):1–9. doi:10.1093/dote/dow020
  4. Mandel KG, Daggy BP, Brodie DA, Jacoby HI. Review article: alginate-raft formulations in the treatment of heartburn and acid reflux. Alimentary Pharmacology & Therapeutics. 2000;14(6):669–690. doi:10.1046/j.1365-2036.2000.00759.x
  5. Strugala V, Avis J, Buxton IR, et al. The role of an alginate suspension on pepsin and bile acids – key aggressors in the gastric refluxate. Does this have implications for the treatment of GORD? Journal of Pharmacy and Pharmacology. 2009;61(8):1021–1028. doi:10.1211/jpp/61.08.0005
  6. Katz PO, Dunbar KB, Schnoll-Sussman FH, Greer KB, Yadlapati R, Spechler SJ. ACG Clinical Guideline for the Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology. 2022;117(1):27–56. doi:10.14309/ajg.0000000000001538
  7. Tytgat GN, Heading RC, Muller-Lissner S, et al. Contemporary understanding and management of reflux and constipation in the general population and pregnancy: a consensus meeting. Alimentary Pharmacology & Therapeutics. 2003;18(3):291–301. doi:10.1046/j.1365-2036.2003.01679.x
  8. World Health Organization (WHO). WHO Model List of Essential Medicines – 23rd List. Geneva: World Health Organization; 2023.
  9. European Medicines Agency (EMA). Summary of Product Characteristics guidelines for antacid and alginate products. 2024.
  10. Quartarone G. Gastroesophageal reflux in pregnancy: a systematic review on the benefit of raft forming agents. Minerva Ginecologica. 2013;65(5):541–549.

Medical Editorial Team

Medical Content

Written by iMedic Medical Editorial Team — Specialists in Gastroenterology and Clinical Pharmacology

Medical Review

Reviewed by iMedic Medical Review Board according to international guidelines (WHO, EMA, BNF, NICE, ACG)

Evidence Standard

Level 1A: Based on systematic reviews, meta-analyses, and randomized controlled trials following the GRADE evidence framework

Editorial Independence

No pharmaceutical company sponsorship or commercial funding. All content is independently produced and free from commercial influence.

Last medical review: | Next scheduled review: